These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 25728920)

  • 21. Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models.
    Nurden AT; Fiore M; Nurden P; Pillois X
    Blood; 2011 Dec; 118(23):5996-6005. PubMed ID: 21917754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of one novel pathogenic
    Lu Z; Nikuze L; Zhong Z; Li F; Zhang F; Liang K; Wei M; Wei H
    Platelets; 2020; 31(3):355-359. PubMed ID: 31088191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. αIIbβ3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia.
    Buitrago L; Rendon A; Liang Y; Simeoni I; Negri A; ; Filizola M; Ouwehand WH; Coller BS
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):E1898-907. PubMed ID: 25827233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains.
    Koker MY; Sarper N; Albayrak C; Zulfikar B; Zengin E; Saraymen B; Albayrak D; Koc B; Avcilar H; Karakükcü M; Chenet C; Bianchi F; de Brevern AG; Petermann R; Jallu V
    Platelets; 2022 May; 33(4):551-561. PubMed ID: 34275420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel amino acid substitution of integrin αIIb in Glanzmann thrombasthenia confirms that the N-terminal region of the receptor plays a role in maintaining β-propeller structure.
    Pillois X; Fiore M; Heilig R; Pico M; Nurden AT
    Platelets; 2013; 24(1):77-80. PubMed ID: 22394243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunisation against αIIbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation Gly540Asp on β3.
    Wihadmadyatami H; Röder L; Berghöfer H; Bein G; Heidinger K; Sachs UJ; Santoso S
    Thromb Haemost; 2016 Aug; 116(2):262-71. PubMed ID: 27098940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of compound heterozygous mutations in the ITGA2B gene in a Chinese patient with Glanzmann thrombasthenia.
    Zheng JY; Jin YH; Zhu YL; Jin PP; Zhang DT; Jin ZB
    Chin Med J (Engl); 2010 Jun; 123(11):1397-401. PubMed ID: 20819594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel 196Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann thrombasthenia.
    Nurden AT; Ruan J; Pasquet JM; Gauthier B; Combrié R; Kunicki T; Nurden P
    Platelets; 2002 Mar; 13(2):101-11. PubMed ID: 11897046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Frameshift Mutation in the ITGB3 Gene Leading to Glanzmann's Thrombasthenia in a Saudi Arabian Family.
    Alharbi A; Hashmi JA; Alharby E; Albalawi AM; Ramzan K; Basit S
    Hematol Oncol Stem Cell Ther; 2022 Mar; 15(1):21-26. PubMed ID: 33600779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel homozygous mutation (c.175delG) in platelet glycoprotein ITGA2B gene as cause of Glanzmann's thrombasthenia type I.
    Vannier C; Behnisch W; Bartsch I; Sandrock K; Ertle F; Schmidt K; Busse A; Superti-Furga A; Kulozik A; Santoso S; Zieger B
    Klin Padiatr; 2010 May; 222(3):150-3. PubMed ID: 20514618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular dynamics analysis of a novel β3 Pro189Ser mutation in a patient with glanzmann thrombasthenia differentially affecting αIIbβ3 and αvβ3 expression.
    Laguerre M; Sabi E; Daly M; Stockley J; Nurden P; Pillois X; Nurden AT
    PLoS One; 2013; 8(11):e78683. PubMed ID: 24236036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type I Glanzmann thrombasthenia caused by an apparently silent beta3 mutation that results in aberrant splicing and reduced beta3 mRNA.
    Xie J; Pabón D; Jayo A; Butta N; González-Manchón C
    Thromb Haemost; 2005 May; 93(5):897-903. PubMed ID: 15886806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SINE-VNTR-Alu retrotransposon insertion as a novel mutational event underlying Glanzmann thrombasthenia.
    Zhang J; Tang J; Li G; Li N; Wang J; Yao R; Yu T
    J Thromb Haemost; 2023 Dec; 21(12):3597-3607. PubMed ID: 37604334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3.
    Mor-Cohen R; Rosenberg N; Peretz H; Landau M; Coller BS; Awidi A; Seligsohn U
    Thromb Haemost; 2007 Dec; 98(6):1257-65. PubMed ID: 18064323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions.
    D'Andrea G; Bafunno V; Del Vecchio L; Amoriello A; Morabito P; Vecchione G; Grandone E; Margaglione M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):657-62. PubMed ID: 18832906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pedigree Analysis and Molecular Mechanism Study of Hereditary Glanzmann Thrombasthenia Caused by Compound Heterozygous Mutation of the ITGA2B Gene].
    Lu XM; Fu DY; Zhang YF; Zhao LD; Wang L; Yang J; Liu J; Zheng JW; Yang LH; Wang G
    Zhonghua Xue Ye Xue Za Zhi; 2024 Apr; 45(4):370-377. PubMed ID: 38951065
    [No Abstract]   [Full Text] [Related]  

  • 37. Alterations of the platelet proteome in type I Glanzmann thrombasthenia caused by different homozygous delG frameshift mutations in ITGA2B.
    Loroch S; Trabold K; Gambaryan S; Reiß C; Schwierczek K; Fleming I; Sickmann A; Behnisch W; Zieger B; Zahedi RP; Walter U; Jurk K
    Thromb Haemost; 2017 Feb; 117(3):556-569. PubMed ID: 28078347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
    Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
    Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients.
    Nelson EJ; Nair SC; Peretz H; Coller BS; Seligsohn U; Chandy M; Srivastava A
    J Thromb Haemost; 2006 Aug; 4(8):1730-7. PubMed ID: 16879215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glanzmann thrombasthenia: state of the art and future directions.
    Nurden AT; Pillois X; Wilcox DA
    Semin Thromb Hemost; 2013 Sep; 39(6):642-55. PubMed ID: 23929305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.